Lv3
360 积分 2025-03-25 加入
Preclinical development of a mutant KRAS targeting therapeutic cancer vaccine
7天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles
3个月前
已完结
Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine
3个月前
已完结
In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring
4个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
4个月前
已完结
A novel safer CD19CAR with shRNA interference of IFN-γ can reduce multiple cytokine levels without significantly compromising its killing efficacy
4个月前
已完结
Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects
6个月前
已完结
Non-clinical development of cancer vaccines: Regulatory considerations
6个月前
已完结
Design and preclinical assessment of mRNA-1345 prefusion F glycoprotein-encoding mRNA vaccine for respiratory syncytial virus
7个月前
已完结
皖公网安备34019202002308
